🟢 Neumora Therapeutics is trading 7.75% up in after-hours trading — no clear catalyst reported

Neumora Therapeutics is trading 7.75% higher after hours at $0.40, following a regular-session close of $0.37 on October 13, 2026; no clear company-specific catalyst surfaced in available reports.

• A report published October 13 noted Wall Street Zen’s downgrade to Strong Sell but did not link it to the move.
• Another market source reported no company headlines that day. The gain followed a sharp regular-session decline, and its cause remains unclear.